SUGAR LAND--July 14, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Within the next three months, the Pharmaceutical-Biotech Industry is expected to launch nearly $6.4 billion worth of North American capital and maintenance (MRO) projects. An analysis by Industrial Info's Pharmaceutical Tracker - Online Database of active capital and MRO projects shows that a 68% jump in spending--from third-quarter 2014's $3.8 billion. Within this article: Details on key projects from major companies, such as Boehringer Ingelheim Vetmedica, Procter & Gamble (NYSE:PG) and Genzyme (NASDAQ:GENZ), as well as Northwestern University.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
